Laboratory Corporation of America Holdings (LH) 140.13 $LH
LabCorp Announces the Availability of the CDC Zika MAC-ELISA Test
BusinessWire - Tue Aug 02, 11:45AM CDT
Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) today announced the nationwide availability of testing for Zika virus using the Zika Immunoglobulin M (IgM) Antibody Capture Enzyme-Linked Immunosorbent Assay (Zika MAC-ELISA) developed by the Centers for Disease Control and Prevention (CDC). The test received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA), initially on February 26, 2016, and reissued on June 29, 2016, for the qualitative detection of Zika virus IgM antibodies in serum or cerebrospinal fluid (collected alongside a patient-matched serum specimen), and is being made available for the first time to commercial laboratories. It is intended to be used in the diagnosis of Zika virus infection in individuals meeting clinical and/or epidemiological criteria established by CDC for Zika virus infection risk.
LH: 140.13 (+0.75)
Laboratory Corp of America Holdings Shares Up 26.3% Since SmarTrend's Buy Recommendation (LH)
Comtex SmarTrend(R) - Tue Aug 02, 12:57AM CDT
SmarTrend identified an Uptrend for Laboratory Corp of America Holdings (NYSE:LH) on February 22nd, 2016 at $110.54. In approximately 5 months, Laboratory Corp of America Holdings has returned 26.31% as of today's recent price of $139.63.
LH: 140.13 (+0.75)
SEQUENOM SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Sequenom, Inc. (SQNM) Over the Proposed Sale of the Company to Laboratory Corporation of America Holdings
PR Newswire - Mon Aug 01, 4:01PM CDT
Nadeem Faruqi, founding partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Sequenom, Inc. ("Sequenom" or the "Company"
(NASDAQ: SQNM) for potential breaches of fiduciary duties in connection with the sale of the Company to Laboratory Corporation of America Holdings for approximately $371 million.
SQNM: 2.36 (unch), LH: 140.13 (+0.75)
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces an Investigation of The Board of Directors of Sequenom, Inc. -SQNM
PR Newswire - Wed Jul 27, 8:36PM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Sequenom, Inc. ("Sequenom" or "the Company" (Nasdaq- SQNM-News) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Laboratory Corporation of America Holdings ("Lab Corp.".
SQNM: 2.36 (unch), LH: 140.13 (+0.75)
LabCorp (LH) Tops Q2 Earnings, View Up, to Buy Sequenom
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 12:16PM CDT
LabCorp (LH) reported a solid second quarter 2016 with adjusted earnings per share (EPS) of $2.31, up 10.5% from the year-ago quarter.
SQNM: 2.36 (unch), BCR: 219.83 (-2.80), LH: 140.13 (+0.75), COO: 181.30 (-0.67)
SEQUENOM, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
BusinessWire - Wed Jul 27, 9:51AM CDT
Rigrodsky & Long, P.A.:
SQNM: 2.36 (unch), LH: 140.13 (+0.75)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation into Whether the Sale of Sequenom Inc. to Laboratory Corporation of America Holdings for $2.40 Per Share is Fair to Shareholders - SQNM
ACCESSWIRE - Wed Jul 27, 8:57AM CDT
NEW YORK, NY / ACCESSWIRE / July 27, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:
SQNM: 2.36 (unch), LH: 140.13 (+0.75)
LabCorp (LH) Tops Q2 Earnings and Revenue Estimates
Aparajita Dutta - Zacks Investment Research - Wed Jul 27, 7:31AM CDT
LabCorp's (LH) adjusted earnings per share of $2.31 beat the Zacks Consensus estimate by a couple of cents.
LH: 140.13 (+0.75)
SEQUENOM (SQNM) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of Sequenom, Inc.; Are Shareholders Getting a Fair Price?
PR Newswire - Wed Jul 27, 6:38AM CDT
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of Sequenom, Inc. (NASDAQ: SQNM) breached their fiduciary duties in connection with the proposed sale of the Company to Laboratory Corporation of America Holdings (NYSE: LH).
SQNM: 2.36 (unch), LH: 140.13 (+0.75)
Hologic (HOLX) Q3 Earnings: A Surprise in the Cards?
Zacks Equity Research - Zacks Investment Research - Tue Jul 19, 6:31AM CDT
Hologic (HOLX) has a Zacks Rank #2 (Buy) which along with a 0.00 % ESP makes surprise prediction difficult.
AGN: 252.53 (+1.78), LH: 140.13 (+0.75), BMY: 74.80 (-0.25), HOLX: 39.00 (-0.03)
Illumina (ILMN) to Report Q2 Earnings: What's in the Cards?
Zacks Equity Research - Zacks Investment Research - Tue Jul 19, 6:08AM CDT
Illumina (ILMN) has a Zacks Rank #4 (Sell), which along with an ESP of 0.00% makes surprise prediction difficult.
AGN: 252.53 (+1.78), LH: 140.13 (+0.75), ILMN: 165.05 (-1.87), BMY: 74.80 (-0.25)
Edwards Lifesciences (EW) Q2 Earnings: Will It Be a Miss?
Zacks Equity Research - Zacks Investment Research - Mon Jul 18, 3:56PM CDT
Edwards (EW) has a Zacks Rank #4 (Sell), which along with a negative ESP of -1.43% makes surprise prediction difficult.
AGN: 252.53 (+1.78), EW: 113.36 (-0.22), LH: 140.13 (+0.75), BMY: 74.80 (-0.25)
Will LabCorp (LH) Beat Earnings Estimates in Q2?
Zacks Equity Research - Zacks Investment Research - Mon Jul 18, 2:27PM CDT
We expect Laboratory Corp. of America Holdings (LH), or LabCorp to beat expectations when it reports second-quarter 2016 results before the opening bell on Jul 27.
MCK: 195.14 (+1.61), BCR: 219.83 (-2.80), LH: 140.13 (+0.75), COO: 181.30 (-0.67)
Laboratory Corp of America Holdings Has Returned 23.4% Since SmarTrend Recommendation (LH)
Comtex SmarTrend(R) - Fri Jul 15, 1:38PM CDT
SmarTrend identified an Uptrend for Laboratory Corp of America Holdings (NYSE:LH) on February 22nd, 2016 at $110.54. In approximately 5 months, Laboratory Corp of America Holdings has returned 23.42% as of today's recent price of $136.44.
LH: 140.13 (+0.75)
Can AngioDynamics' (ANGO) Q4 Earnings Pull a Surprise?
Zacks Equity Research - Zacks Investment Research - Fri Jul 08, 9:25AM CDT
AngioDynamics Inc (ANGO) is set to report fourth-quarter fiscal 2016 results on Jul 13.
PMC: 26.46 (+0.39), LH: 140.13 (+0.75), ANGO: 15.19 (-0.11), COO: 181.30 (-0.67)
Zacks.com featured highlights: Equinix, LPL Financial, Laboratory Corp. of America, Two Harbors Investment and Trinity Industries
Zacks Equity Research - Zacks Investment Research - Fri Jul 08, 8:30AM CDT
Zacks.com featured highlights: Equinix, LPL Financial, Laboratory Corp. of America, Two Harbors Investment and Trinity Industries
EQIX: 370.34 (-3.12), TRN: 22.99 (+0.27), TWO: 8.78 (+0.12), LH: 140.13 (+0.75), LPLA: 25.63 (+0.85)
VWR Corp Poised on Balanced Growth, Strong Fundamentals
Zacks Equity Research - Zacks Investment Research - Fri Jul 08, 7:18AM CDT
On Jul 7, we issued an updated research report on Radnor, PA-based VWR Corporation (VWR).
BCR: 219.83 (-2.80), VWR: 30.75 (-0.01), LH: 140.13 (+0.75), COO: 181.30 (-0.67)
5 Strong Sales Growth Stocks to Power Your Portfolio
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 9:19AM CDT
The Price-to-Sales (P/S) ratio can turn out to be an appropriate metric for stock valuation - Equinix, Inc. (EQIX), LPL Financial Holdings Inc. (LPLA), Laboratory Corp. of America Holdings (LH).
EQIX: 370.34 (-3.12), TWO: 8.78 (+0.12), TRN: 22.99 (+0.27), LH: 140.13 (+0.75), LPLA: 25.63 (+0.85)
LabCorp Sees Balanced Growth; Covance Synergy on Track
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 6:00AM CDT
On Jun 20, 2016, we issued an updated research report on Laboratory Corporation of America Holdings (LH).
BCR: 219.83 (-2.80), LH: 140.13 (+0.75), HSIC: 179.68 (-0.27), COO: 181.30 (-0.67)
LabCorp Announces the Availability of the CDC Zika MAC-ELISA Test
BusinessWire - Tue Aug 02, 11:45AM CDT
Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) today announced the nationwide availability of testing for Zika virus using the Zika Immunoglobulin M (IgM) Antibody Capture Enzyme-Linked Immunosorbent Assay (Zika MAC-ELISA) developed by the Centers for Disease Control and Prevention (CDC). The test received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA), initially on February 26, 2016, and reissued on June 29, 2016, for the qualitative detection of Zika virus IgM antibodies in serum or cerebrospinal fluid (collected alongside a patient-matched serum specimen), and is being made available for the first time to commercial laboratories. It is intended to be used in the diagnosis of Zika virus infection in individuals meeting clinical and/or epidemiological criteria established by CDC for Zika virus infection risk.
LH: 140.13 (+0.75)
Laboratory Corp of America Holdings Shares Up 26.3% Since SmarTrend's Buy Recommendation (LH)
Comtex SmarTrend(R) - Tue Aug 02, 12:57AM CDT
SmarTrend identified an Uptrend for Laboratory Corp of America Holdings (NYSE:LH) on February 22nd, 2016 at $110.54. In approximately 5 months, Laboratory Corp of America Holdings has returned 26.31% as of today's recent price of $139.63.
LH: 140.13 (+0.75)
SEQUENOM SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Sequenom, Inc. (SQNM) Over the Proposed Sale of the Company to Laboratory Corporation of America Holdings
PR Newswire - Mon Aug 01, 4:01PM CDT
Nadeem Faruqi, founding partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Sequenom, Inc. ("Sequenom" or the "Company"
(NASDAQ: SQNM) for potential breaches of fiduciary duties in connection with the sale of the Company to Laboratory Corporation of America Holdings for approximately $371 million. SQNM: 2.36 (unch), LH: 140.13 (+0.75)
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces an Investigation of The Board of Directors of Sequenom, Inc. -SQNM
PR Newswire - Wed Jul 27, 8:36PM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Sequenom, Inc. ("Sequenom" or "the Company"
(Nasdaq- SQNM-News) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Laboratory Corporation of America Holdings ("Lab Corp.". SQNM: 2.36 (unch), LH: 140.13 (+0.75)
LabCorp (LH) Tops Q2 Earnings, View Up, to Buy Sequenom
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 12:16PM CDT
LabCorp (LH) reported a solid second quarter 2016 with adjusted earnings per share (EPS) of $2.31, up 10.5% from the year-ago quarter.
SQNM: 2.36 (unch), BCR: 219.83 (-2.80), LH: 140.13 (+0.75), COO: 181.30 (-0.67)
SEQUENOM, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
BusinessWire - Wed Jul 27, 9:51AM CDT
Rigrodsky & Long, P.A.:
SQNM: 2.36 (unch), LH: 140.13 (+0.75)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation into Whether the Sale of Sequenom Inc. to Laboratory Corporation of America Holdings for $2.40 Per Share is Fair to Shareholders - SQNM
ACCESSWIRE - Wed Jul 27, 8:57AM CDT
NEW YORK, NY / ACCESSWIRE / July 27, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:
SQNM: 2.36 (unch), LH: 140.13 (+0.75)
LabCorp (LH) Tops Q2 Earnings and Revenue Estimates
Aparajita Dutta - Zacks Investment Research - Wed Jul 27, 7:31AM CDT
LabCorp's (LH) adjusted earnings per share of $2.31 beat the Zacks Consensus estimate by a couple of cents.
LH: 140.13 (+0.75)
SEQUENOM (SQNM) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of Sequenom, Inc.; Are Shareholders Getting a Fair Price?
PR Newswire - Wed Jul 27, 6:38AM CDT
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of Sequenom, Inc. (NASDAQ: SQNM) breached their fiduciary duties in connection with the proposed sale of the Company to Laboratory Corporation of America Holdings (NYSE: LH).
SQNM: 2.36 (unch), LH: 140.13 (+0.75)
Hologic (HOLX) Q3 Earnings: A Surprise in the Cards?
Zacks Equity Research - Zacks Investment Research - Tue Jul 19, 6:31AM CDT
Hologic (HOLX) has a Zacks Rank #2 (Buy) which along with a 0.00 % ESP makes surprise prediction difficult.
AGN: 252.53 (+1.78), LH: 140.13 (+0.75), BMY: 74.80 (-0.25), HOLX: 39.00 (-0.03)
Illumina (ILMN) to Report Q2 Earnings: What's in the Cards?
Zacks Equity Research - Zacks Investment Research - Tue Jul 19, 6:08AM CDT
Illumina (ILMN) has a Zacks Rank #4 (Sell), which along with an ESP of 0.00% makes surprise prediction difficult.
AGN: 252.53 (+1.78), LH: 140.13 (+0.75), ILMN: 165.05 (-1.87), BMY: 74.80 (-0.25)
Edwards Lifesciences (EW) Q2 Earnings: Will It Be a Miss?
Zacks Equity Research - Zacks Investment Research - Mon Jul 18, 3:56PM CDT
Edwards (EW) has a Zacks Rank #4 (Sell), which along with a negative ESP of -1.43% makes surprise prediction difficult.
AGN: 252.53 (+1.78), EW: 113.36 (-0.22), LH: 140.13 (+0.75), BMY: 74.80 (-0.25)
Will LabCorp (LH) Beat Earnings Estimates in Q2?
Zacks Equity Research - Zacks Investment Research - Mon Jul 18, 2:27PM CDT
We expect Laboratory Corp. of America Holdings (LH), or LabCorp to beat expectations when it reports second-quarter 2016 results before the opening bell on Jul 27.
MCK: 195.14 (+1.61), BCR: 219.83 (-2.80), LH: 140.13 (+0.75), COO: 181.30 (-0.67)
Laboratory Corp of America Holdings Has Returned 23.4% Since SmarTrend Recommendation (LH)
Comtex SmarTrend(R) - Fri Jul 15, 1:38PM CDT
SmarTrend identified an Uptrend for Laboratory Corp of America Holdings (NYSE:LH) on February 22nd, 2016 at $110.54. In approximately 5 months, Laboratory Corp of America Holdings has returned 23.42% as of today's recent price of $136.44.
LH: 140.13 (+0.75)
Can AngioDynamics' (ANGO) Q4 Earnings Pull a Surprise?
Zacks Equity Research - Zacks Investment Research - Fri Jul 08, 9:25AM CDT
AngioDynamics Inc (ANGO) is set to report fourth-quarter fiscal 2016 results on Jul 13.
PMC: 26.46 (+0.39), LH: 140.13 (+0.75), ANGO: 15.19 (-0.11), COO: 181.30 (-0.67)
Zacks.com featured highlights: Equinix, LPL Financial, Laboratory Corp. of America, Two Harbors Investment and Trinity Industries
Zacks Equity Research - Zacks Investment Research - Fri Jul 08, 8:30AM CDT
Zacks.com featured highlights: Equinix, LPL Financial, Laboratory Corp. of America, Two Harbors Investment and Trinity Industries
EQIX: 370.34 (-3.12), TRN: 22.99 (+0.27), TWO: 8.78 (+0.12), LH: 140.13 (+0.75), LPLA: 25.63 (+0.85)
VWR Corp Poised on Balanced Growth, Strong Fundamentals
Zacks Equity Research - Zacks Investment Research - Fri Jul 08, 7:18AM CDT
On Jul 7, we issued an updated research report on Radnor, PA-based VWR Corporation (VWR).
BCR: 219.83 (-2.80), VWR: 30.75 (-0.01), LH: 140.13 (+0.75), COO: 181.30 (-0.67)
5 Strong Sales Growth Stocks to Power Your Portfolio
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 9:19AM CDT
The Price-to-Sales (P/S) ratio can turn out to be an appropriate metric for stock valuation - Equinix, Inc. (EQIX), LPL Financial Holdings Inc. (LPLA), Laboratory Corp. of America Holdings (LH).
EQIX: 370.34 (-3.12), TWO: 8.78 (+0.12), TRN: 22.99 (+0.27), LH: 140.13 (+0.75), LPLA: 25.63 (+0.85)
LabCorp Sees Balanced Growth; Covance Synergy on Track
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 6:00AM CDT
On Jun 20, 2016, we issued an updated research report on Laboratory Corporation of America Holdings (LH).
BCR: 219.83 (-2.80), LH: 140.13 (+0.75), HSIC: 179.68 (-0.27), COO: 181.30 (-0.67)
